Frontiers in Helicobacter pylori research: Pathogenesis, host response, vaccine development and new therapeutic approaches

European Journal of Gastroenterology and Hepatology

Volumn 8, Issue 7, 1996, Pages 717-722

  Michetti, Pierre ^a,e   Wadström, Torkel ^b   Kraehenbuhl, Jean Pierre ^c   Lee, Adrian ^d   Kreiss, Christianna ^a   Blum, André L ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e POLICLINIQUE MÉDICALE UNIVERSITAIRE   (Switzerland)

Author keywords

Bacterial infection; Helicobacter pylori; Host response; Pathogenesis; Vaccine

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL ANTIGEN; VACCINE;

BACTERIAL INFECTION; GASTROENTEROLOGY; GENOME; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TISSUE INJURY; VACCINE PRODUCTION;

ANIMALS; BACTERIAL VACCINES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNIZATION; IMMUNIZATION, PASSIVE;

EID: 0029901022     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (23)

1. Melchers K, Weitzenegger T, Steinhilber W, Sachs C, Schäfer KP: A novel P type ATPase cloned from Helicobacter pylori. Gastroenterology 1995, 108:A165.
2. Madara JL: Migration of neutrophils through epithelial monolayers. Trends Cell Biol 1994, 4:4-7.
3. Huber AR, Kunkel SL, Todd RF III, Weiss SJ: Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991, 254:99-102.
4. Blaser MJ: Hypotheses on the pathogenesis and natural history of Helicobacter pylori induced inflammation. Gastroenterology 1992, 102:720-727.
5. Stolte M, Stadelmann O, Bethke B, Burkard G: Relationships between the degree of Helicobacter pylori colonisation and the degree and activity of gastritis, surface epithelial degeneration and mucus secretion. Z Gastroenterol 1995, 33:89-93.
6. Engstrand L, Scheynius A, Pahlson C, Grimelius L, Schwan A, Gustavsson S: Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect Immun 1989, 57:827-832.
7. Sharma SA, Miller GG, Perez-Perez GI, Gupta RS, Blaser MJ: Humoral and cellular immune recognition of Helicobacter pylori proteins are not concordant. Clin Exp Immunol 1994, 97:126-132.
8. Hanson LA, Telemo E, Wiedermann U, Dahlman A, Saalman R, Ahlstedt S, et al.: Sensitization and development of tolerance via the gut. Pediatr Allergy Immunol 1993, 4:16-20.
9. Czinn SJ, Nedrud JG: Oral immunization against Helicobacter pylori. Infect Immun 1991, 59:2359-2363.
10. Chen MH, Lee A, Hazell S, Hu PJ, Li YY: Immunisation against gastric infection with Helicobacter species - first step in the prophylaxis of gastric cancer? Zbl Bakt (Int J Med Microbiol) 1993, 280:155-165.
11. Michetti P, Corthesy-Theulaz I, Davin C, Haas, R, Vaney AC, Heitz M, et al.: Immunisation of BALB/c mice against Helicobacter felis infection with H. pylori urease. Gastroenterology 1994, 107:1002-1011.
12. Lee CK, Weltzin R, Thomas WD, Kleanthous H, Ermak TH, Soman, G, et al.: Oral immunization with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis 1995, 172:161-172.
13. Ferrero RL, Thiberge JM, Kansau I, Wuscher N, Huerre M, Labigne A: The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. PNAS 1995, 92:6499-6503.
14. Corthesy-Theulaz J, Porta N, Glauser M, Saraga E, Vaney AC, Haas R, et al.: Oral immunization with Helicobacter pylori urease B subunit as a treatment against Helicobacter infection in mice. Gastroenterology 1995, 109:115-121.
15. Doidge C, Gust I, Lee A, Buck F, Hazell S, Manne U: Therapeutic immunisation against Helicobacter infection. Lancet 1994, 343:914-915.
16. Marchetti M, Arico B, Burroni D, Figura N, Rappuoli R, Ghiara P: Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science 1995, 267:1655-1658.
17. Lee A, Buck F: Vaccination and mucosal responses to Helicobacter pylori infection. Aliment Pharmacol Ther 1996, 10(suppl. 1) In press.
18. Mobley HL, Garner RM, Bauerfeind P: Helicobacter pylori nickel-transport gene nixA: synthesis of catalytically active urease in Escherichia coli independent of growth conditions. Mol Microbiol 16:97-109.
19. Mendz GL, Hazell SL, Srinivasan S: Fumarate reductase: a target for therapeutic intervention against Helicobacter pylori. Arch Biochem Biophys 1995, 321:153-159.
20. Michetti P, Dorta G, Brassard D, Vouillamoz D, Schwizer W, Felley C, et al.: L. acidophilus supernatant as an adjuvant in the therapy of H. pylori in humans. Gastroenterology 1995, 108:A166.
21. Korhonen H, Syväoja EL, Ahola-Luttila H, Sivelä S, Kopola S, Husu J, et al.: Bactericidal effect of bovine normal and immune serum, colostrum and milk against Helicobacter pylori. J Appl Bacteriol 1995, 78:655-662.
22. Falk P, Roth KA, Borén T, Ulf Westblom T, Gordon JI, Normark S: An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium. PNAS 1993, 90:2035-2039.
23. Dial EJ, Serna JH, Lichtenberger LM: Lactoferrin inhibits the growth of Helicobacter pylori in vitro. Gastroenterology 1995, 108:A82.